{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:59:34Z","timestamp":1780937974444,"version":"3.54.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Previous studies and society guidelines have proposed probiotics as a complementary therapy for acute infectious diarrhea, which may shorten the disease course, yet strain-specific effects and microbiome correlates remain incompletely defined. We aim to evaluate the effect of a combination of\n                      <jats:italic>Lactobacillus acidophilus<\/jats:italic>\n                      and\n                      <jats:italic>Limosilactobacillus reuteri<\/jats:italic>\n                      on the duration of diarrhea and gut microbiota composition in children with acute infectious diarrhea.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient and methods<\/jats:title>\n                    <jats:p>\n                      In a prospective, randomized, controlled, open-label trial at a tertiary pediatric emergency department (March\u2013August 2024), children aged 1\u20136 years with acute infectious diarrhea lasting less than 24 h were allocated 1:1 to standard therapy (oral rehydration \u00b1 intravenous fluids) with or without 5-day probiotic (\n                      <jats:italic>L. acidophilus<\/jats:italic>\n                      DSMZ 26280; 108 CFU) and (\n                      <jats:italic>L. reuteri<\/jats:italic>\n                      DSMZ 25441; 108 CFU). Primary outcomes were duration of diarrhea and the proportion diarrhea-free at 72 h. The secondary outcome measures included the proportion of diarrhea-free children during first 10th day of the study. A subgroup analysis for gut microbiota composition at Day 0, 10th and 30th days of the study have been performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 145 enrolled children, 79 in the probiotic group (34 girls, 45 boys) and 66 in the control (30 girls and 36 boys); baseline demographics were comparable. The duration of diarrhea was significantly reduced in the probiotic group compared to the control group (46.4 \u00b1 29.6 h vs. 81.6 \u00b1 38.5 h,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). The percentage of diarrhea-free children was significantly larger in the probiotic group at 72 h compared to the control (86.0% vs. 33.3%,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). Persistence of diarrhea was lower in the probiotic group at 24, 48, and 96 h (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) and at day 6 (2.5% vs. 15.1%;\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05); by days 7\u201310, persistence was rare in both groups. The probiotic combination is well-tolerated, and no adverse events have been reported. Alpha diversity indices were unchanged within\/between groups. Bray\u2013Curtis and Jaccard PCoA showed no between-group separation; unweighted UniFrac revealed differences within the probiotic group (day 1 vs. day 30) and between groups at day 30 (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). LEfSe indicated enrichment of taxa associated with recovery in the probiotic arm and control group, and there is difference between group at Day 30.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study evaluates a specific combination of\n                      <jats:italic>L. acidophilus<\/jats:italic>\n                      DSMZ 26280 and\n                      <jats:italic>L. reuteri<\/jats:italic>\n                      DSMZ 25441 in a randomized controlled setting, adding to the growing body of strain-specific probiotic research in pediatric acute infectious diarrhea. Adding probiotics to treatment is well-tolerated and reduces the duration of diarrhea by approximately 35 h when it starts in the early hours of infection. This probiotic combination use is associated with modest phylogenetics shifts in gut microbiota composition, with enrichment of certain taxa that have been previously associated with gut homeostasis in other contexts; however, their functional and clinical significance in this setting remains unclear. Larger blinded trials are warranted to confirm durability and detailed metagenomic analysis including metabolomics.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1792126","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:14:18Z","timestamp":1780935258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The combination of Lactobacillus acidophilus DSMZ 26280 and Limosilactobacillus reuteri DSMZ 25441 has an impact on clinical course and gut microbiota of children with acute infectious diarrhea"],"prefix":"10.3389","volume":"17","author":[{"given":"Necibe Tugce","family":"Goktas","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Sancaktepe Ilhan Varank Research and Training Hospital, University of Health Sciences","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirin","family":"Guven","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Sancaktepe Ilhan Varank Research and Training Hospital, University of Health Sciences","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Eskisehir Osmangazi University Faculty of Medicine","place":["Eskisehir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/nu14030682","article-title":"Systematic review and meta-analysis: Lactobacillus acidophilus for treating acute gastroenteritis in children","volume":"14","author":"Cheng","year":"2022","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jped.2014.10.009","article-title":"Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting","volume":"91","author":"Dinleyici","year":"","journal-title":"J. Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00431-012-1903-5","article-title":"The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: single blinded randomized study","volume":"172","author":"Dinleyici","year":"2013","journal-title":"Eur. J. Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3920\/BM2014.0086","article-title":"Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea","volume":"6","author":"Dinleyici","year":"","journal-title":"Benef. Microbes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fmicb.2018.01230","article-title":"Time series analysis of the microbiota of children suffering from acute infectious diarrhea and their recovery after treatment","volume":"9","author":"Dinleyici","year":"2018","journal-title":"Front. Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1111\/apa.12617","article-title":"Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children","volume":"103","author":"Dinleyici","year":"2014","journal-title":"Acta Paediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1039\/C8FO00376A","article-title":"Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children","volume":"9","author":"do Carmo M","year":"2018","journal-title":"Food Funct"},{"key":"B8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(24)00691-1","article-title":"Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021","volume":"25","year":"2025","journal-title":"Lancet Infect. Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/MPG.0000000000002669","article-title":"Acute gastroenteritis in children of the world: what needs to be done?","volume":"70","author":"Guarino","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MPG.0000000000000375","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition\/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014","volume":"59","author":"Guarino","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/MPG.0000000000003568","article-title":"Synbiotics in the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications","volume":"76","author":"Hojsak","year":"2023","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jpn3.12134","article-title":"Prebiotics in the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications","volume":"78","author":"Indrio","year":"2024","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis","volume":"5","author":"McFarland","year":"2018","journal-title":"Front. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"mgen000476","DOI":"10.1099\/mgen.0.000476","article-title":"Comprehensive genome analyses of Sellimonas intestinalis, a potential biomarker of homeostasis gut recovery","volume":"6","author":"Mu\u00f1oz","year":"2020","journal-title":"Microb. Genom"},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-031-58572-2_9","article-title":"Acute infectious diarrhea","volume":"1449","author":"Poeta","year":"2024","journal-title":"Adv. Exp. Med. Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MPG.0000000000003633","article-title":"Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications","volume":"76","author":"Szajewska","year":"2023","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MCO.0000000000000909","article-title":"Evidence on postbiotics in infants and children","volume":"26","author":"Szajewska","year":"2023","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/INF.0000000000003128","article-title":"Gut microbiota in Mexican children with acute diarrhea: an observational study","volume":"40","author":"Toro Monjaraz","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/MCO.0000000000001192","article-title":"An update on probiotics in paediatrics","volume":"29","author":"Zem\u0142a","year":"2026","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1792126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:14:19Z","timestamp":1780935259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1792126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":19,"alternative-id":["10.3389\/fmicb.2026.1792126"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1792126","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1792126"}}